Payer mix shift impacting margins
Increase in scheme business (CGHS/ECHS) and higher share of lower-margin specialties (ortho, onco) compressed hospital EBITDA margins by ~2% in Q1.
medium · management_commentary
Fortis Healthcare Limited — Q1 FY25
Fortis Healthcare delivered a strong Q1 FY25 with consolidated revenue of INR 1,859 crore (+12.2% YoY) and EBITDA of INR 343 crore (+25.5% YoY), driven by the hospital business...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Agilus underperformance and brand transition drag
Diagnostics revenue remained flat YoY, with margins declining due to rebranding costs and government provisions; recovery may take longer than expected.
medium · analyst_questionLegal costs from Daiichi dispute to persist
Legal costs related to the Daiichi litigation are expected to remain high this year, with potential appeals adding uncertainty.
medium · analyst_questionGeopolitical risks impacting medical travel
Recent developments in Bangladesh and Israel may affect international patient flows, though management expects no material impact.
low · analyst_question